Mbarara University of Science and Technology: Clinical Trials

91 trials sponsored by Mbarara University of Science and Technology, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

57 completed, 20 unknown, 5 recruiting, 4 not yet recruiting. 62 Not applicable, 7 Phase 3, 5 Phase 2, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable62Completed 33, Unknown 17, Not yet recruiting 4, Recruiting 4, Active not recruiting 3, Terminated 1
Phase 37Completed 5, Terminated 1, Unknown 1
Phase 25Completed 2, Unknown 2, Recruiting 1
Phase 42Completed 2
Phase 11Completed 1

Follow Mbarara University of Science and Technology: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Insecticide-Treated Baby Wraps for the Prevention of Malaria
Permethrin-treated lesu, Etofenprox-treated lesu, Untreated lesu - Malaria (Plasmodium Falciparum), Malaria Incidence
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill12962027-01-012026-08-19
Developing an HIV Disclosure Intervention for Men in Uganda
HIV disclosure intervention - HIV Infections, Sexually Transmitted Infections (Not HIV or Hepatitis)
Not applicableNot yet recruitingBrigham and Women's Hospital702026-09-012026-07-16
The Feasibility and Acceptability of a Post-tuberculosis Lung Disease Diagnostic Algorithm in Uganda.
A novel PTLD clinical diagnostic algorithm - Post Pulmonary Tuberculosis, Post-Tuberculous Bronchiectasis
Not applicableNot yet recruitingMbarara University of Science and Technology802026-09-012025-07-16
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
PNF - HIV norms, PNF - Alcohol use norms, PNF - HIV and alcohol use norms - HIV (Human Immunodeficiency Virus), Alcohol Misuse
Not applicableNot yet recruitingVanderbilt University13502026-09-012026-07-28
BPaLMZ for TB Meningitis
BPaLMZ Regimen - Tuberculous Meningitis, HIV
Phase 2RecruitingDavid Boulware3122026-07-282026-10-16
IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding
Dihydroartemisinin piperaquine, Dihydroartemisinin piperaquine + Bacillus thuringiensis israelensis, Long-lasting Insecticidal Net - Malaria Infection, Malaria Falciparum
Not applicableActive not recruitingUniversity of North Carolina, Chapel Hill360002025-03-122026-09-22
Improving Access to HIV Testing for Children in Uganda
HIV saliva swab screening test, Referral for HIV testing - HIV (Human Immunodeficiency Virus)
Not applicableActive not recruitingUniversity of California, San Francisco4002025-01-192026-10-13
Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy.
Self-MAnagement intervention for Reducing The epilepsy burden among Ugandans - Epilepsy
Not applicableActive not recruitingMakerere University1902025-01-062026-05-11
A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda
A social media based intervention - Adolescent Behavior
Not applicableRecruitingMbarara University of Science and Technology1052024-10-252025-05-18
Education of Pregnant Women With a Prenatal Indication for Cesarean Section Through Periodic Short Message Service (SMS) and Interactive Voice Response System (IVR) in Uganda
SMS and Interactive Voice Response (IVR) Educational Intervention - High Risk Pregnancy, Cesarean Section
Not applicableCompletedMassachusetts General Hospital712024-06-112026-07-10
Mobile Health Intervention (Support-moms) in Antenatal Care to Improve Maternal Health in Uganda
Support-Moms, Control - Maternal Health
Not applicableRecruitingMbarara University of Science and Technology16802024-05-012024-08-05
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis
AMBITION trial control, Flucytosine - Cryptococcal Meningitis
Phase 2CompletedUniversity of Minnesota482024-04-092025-08-27
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
Standard of Care treatment strategy, Individualized Care treatment strategy, Immediate Switch - HIV Infections, AIDS
Not applicableRecruitingMassachusetts General Hospital6482024-02-072026-03-19
Personalized Normative Feedback to Increase HIV Testing
Survey questionnaire - HIV Testing, HIV Stigma
Not applicableCompletedMassachusetts General Hospital13002023-11-022026-06-01
Question-Order Effect Experiment to Measure HIV Stigma
Survey questionnaire V1, Survey questionnaire V2 - HIV
Not applicableCompletedMassachusetts General Hospital1802023-11-022026-06-01
Self-management of HIV Among Adolescents
Empowerment and personal transformation intervention - HIV
Not applicableCompletedMbarara University of Science and Technology802023-08-192024-04-30
WHO Labor Care Guide for Obstetric Care Providers in Public Health Facilities in Mbarara, Southwestern Uganda
Labor Care Guide - Intrapartum Fetal Monitoring
Not applicableUnknownMbarara University of Science and Technology5202023-08-012023-08-07
Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda
Omuyambi, Control - HIV Infections
Not applicableRecruitingWeill Medical College of Cornell University6502023-07-202026-04-20
The Effect of Household Air Pollution on Lung Function Growth in Infants With Pneumonia in Sub-Saharan Africa
Clean Air Intervention - Pneumonia, Pollution; Exposure
Not applicableUnknownMassachusetts General Hospital252023-05-012023-10-18
My Mobile Wallet: An Intervention for Tuberculosis Medication Adherence in Rural Uganda
SMS texts + incentives + Wisepill device for medication monitoring, SMS texts only + Wisepill device for medication monitoring, Wisepill device for medication monitoring only - Tuberculosis
Not applicableUnknownMbarara University of Science and Technology2422022-04-142022-12-19

Showing 20 of 91. Sign in to see all of them.

Conditions studied

Acquired Immunodeficiency Syndrome (14)  ·  Tuberculosis (10)  ·  HIV Infections (8)  ·  Malaria (6)  ·  Medication Adherence (4)  ·  Pneumonia (4)  ·  Alcohol Drinking (3)  ·  Meningitis (3)  ·  Meningitis, Cryptococcal (3)  ·  Sexually Transmitted Diseases (3)  ·  Alcoholism (2)  ·  COVID-19 (2)  ·  Cryptococcosis (2)  ·  Hypertension (2)  ·  Malaria, Falciparum (2)

Interventions

Surveys and Questionnaires (6)  ·  Air (2)  ·  Artemether, Lumefantrine Drug Combination (2)  ·  Enhanced Recovery After Surgery (2)  ·  Sertraline (2)  ·  Spermine Synthase (2)  ·  Acetaminophen (1)  ·  Ambulatory Care Facilities (1)  ·  Amoxicillin (1)  ·  Anti-Infective Agents, Local (1)  ·  Artesunate (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Ethanol (1)  ·  Fluconazole (1)  ·  Flucytosine (1)

Countries

Uganda (79)  ·  South Africa (5)  ·  Burkina Faso (2)  ·  Ghana (2)  ·  Canada (1)  ·  Gabon (1)  ·  Mozambique (1)  ·  Nigeria (1)  ·  Rwanda (1)  ·  Tanzania (1)  ·  United States (1)  ·  Zambia (1)

Top investigators

Alexander C Tsai, MD, PhD (7)  ·  Bernard Kakuhikire, MBA (4)  ·  Alexander C Tsai, MD (3)  ·  Angella Musiimenta, PhD (3)  ·  Santorini Data, MD (3)  ·  Adeline A Boatin, MD MPH (2)  ·  Data Santorino, MD (2)  ·  Jackson Mukonzo, PhD (2)  ·  Jessica Haberer, MD (2)  ·  Judith A Hahn, PhD, MA (2)  ·  Radhika Sundararajan, MD, PhD (2)  ·  Alfred Tiono, PhD (1)  ·  Amir Abdallah, MD (1)  ·  Amon Agaba, PhD (1)

Results publications

PMID 30325463, PMID 32843994, PMID 39972326, PMID 10546786, PMID 11242178, PMID 11502341, PMID 11647150, PMID 11873017, PMID 22087077, PMID 22720901, PMID 23967069, PMID 24093828, PMID 24963568, PMID 25369200, PMID 25633626, PMID 25831269, PMID 26144389, PMID 26149722, PMID 26760452, PMID 28542176, PMID 29655949, PMID 29773527, PMID 29946683, PMID 30256903, PMID 30345376, PMID 30626191, PMID 31226123, PMID 31242860, PMID 31319498, PMID 31345462, PMID 31504335, PMID 31549001, PMID 32415846, PMID 32525954, PMID 32580252, PMID 33146628, PMID 33541340, PMID 33565123, PMID 33579213, PMID 33677986, PMID 34016158, PMID 34096320, PMID 34131487, PMID 34678199, PMID 34689732, PMID 34698502, PMID 34755438, PMID 35225388, PMID 35324081, PMID 35465375

NIH funding

R01MH125667 (2), F32HL124951 (1), K23AI143470 (1), K23HD097300 (1), K23MH087228 (1), K23MH111409 (1), K23MH126771 (1), K43TW012640 (1), K43TW012781 (1), R01AA031936 (1), R01AI124718 (1), R01AI167699 (1), R01AI173558 (1), R01HD111692 (1), R01MH080662 (1)